Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Oct 20, 2026

Press release

BostonGene and Medical University of South Carolina Announce Strategic Collaboration to Advance CAR-T Therapy Insights for Lymphoma and Leukemia

Collaboration leverages biologically grounded AI and multimodal immune system profiling via RNA sequencing and flow cytometry to identify predictive biomarkers of CAR-T response, toxicity, persistence, and immune dynamicsWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI model for tumor and immune biology, today announced a new research collaboration with the Medical University of South Carolina (MUSC). The collaboration will leverage BostonGene’s biologically grounded AI p
Press release cover image

Oct 20, 2026

Press release

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

GeneDx combines clinical expertise with a phenotype-driven approach to solve complex genetic cases and deliver answers soonerGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its genome testing portfolio with long-read whole genome sequencing (lrWGS).Long-read sequencing analyzes longer stretches of DNA to identify complex genetic variation, including certain stru
Press release cover image

Oct 20, 2026

Press release

Prenosis and Carle Health Mark Sepsis ImmunoScore® Clinical Deployment and First Patients Enrolled in OBSERVE-ARDS Clinical Study

Carle Health, a Prenosis investor and research partner, becomes the first site in Prenosis' ARDS clinical study program as Immunix®-integrated sites accelerate future researchCHICAGO, Oct. 20, 2026 /PRNewswire/ -- Prenosis®, a biology-based technology company delivering precision therapeutics, today announced three milestones in its ongoing relationship with Carle Health: the clinical deployment of Sepsis ImmunoScore® in support of Prenosis' Clinical Utility and Performance of the Sepsis ImmunoS
Press release cover image

Oct 20, 2026

Press release

Parse Biosciences Launches Evercode MAX, Enabling Researchers to Profile More Cells and Samples with Greater Flexibility

New modular platform gives researchers greater control over sample and cell throughput while optimizing valueSEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and accessible single cell sequencing and a QIAGEN company, today announced that Evercode™ MAX, a modular configuration of its flagship Evercode single cell sequencing platform, is now shipping to customers. Using the same instrument-free workflow, researchers can profile up to 2.5 times as many cells across up
Press release cover image

Oct 20, 2026

Press release

Sinopia Biosciences Secures $2.5 Million NIH Grant to Advance Metabolomics Foundation Model for Drug Discovery

NIGMS SBIR Phase II award will support development of an AI-powered metabolomics foundation model designed to unify insights across metabolomics data and accelerate therapeutic discovery through Sinopia's LEADS® platformSAN DIEGO--(BUSINESS WIRE)--Sinopia Biosciences, Inc., a biotechnology company leveraging multi-omics data, high-throughput screening, and artificial intelligence to identify and develop first-in-class therapies for diseases with significant unmet need, today announced it has bee
A minimalist representation of a face with a clock, symbolizing biological age in cancer prediction.

Oct 20, 2026

AI tool uses face photos to predict cancer survival

Researchers have unveiled a groundbreaking AI model capable of predicting cancer survival risk using just facial photographs. Developed by a team from Mass General Brigham, this model employs two algorithms: one estimating biological age and the other directly forecasting survival outcomes.The first algorithm, known as FAHR-FaceAge, demonstrated an impressive accuracy in identifying biological age, with a margin of error around five years. This accuracy surpasses that of existing tools, and nota
Press release cover image

Oct 20, 2026

Press release

Philips highlights Integrated Diagnostics’ role in the future of cardiovascular informatics following MediReport acquisition

October 20, 2026 Advanced reporting and workflow capabilities developed by MediReport are expected to complement Philips’ cardiovascular informatics portfolio and support its evolution toward a more connected, AI-enabled and cloud-ready cardiovascular experience.  Amsterdam, the Netherlands – October 20, 2026 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how advanced reporting and workflow capabilities developed by MediReport are expected to comp
A permafrost core sample on the Arctic tundra

Oct 20, 2026

Canada’s Arctic Research Could Help Discover Next-Gen Therapeutics

Exploration of Canada’s Arctic permafrost may unveil new therapeutic compounds, but ethical considerations loom large.Canadian scientists are investigating the Arctic tundra's permafrost, which holds ancient DNA and potentially valuable microorganisms for drug development. Utilizing advanced genomic techniques, researchers aim to uncover biosynthetic gene clusters that could lead to innovative antibiotics and other therapeutics. The historical significance of these organisms, some preserved for
Press release cover image

Oct 20, 2026

Press release

Johnson & Johnson to Showcase the Future of Surgical Intelligence at Abu Dhabi Future Health Summit 2026

Company to showcase MONARCH™ robotics platform and Polyphonic™ digital ecosystemNew ecosystem collaboration announced at the event will support the future of surgical intelligenceABU DHABI, United Arab Emirates--(BUSINESS WIRE)--#PressRelease--Johnson & Johnson will showcase digital surgery technologies and its strategic collaboration with the Department of Health – Abu Dhabi (DOH), to advance surgical intelligence at the Abu Dhabi Future Health Summit 2026, joining leaders from healthcare,
A clipboard with clinical trial metrics on a desk in an office setting.

Oct 20, 2026

Advocacy organization launches data dashboard to better assess how clinical trial sites perform

The Society for Clinical Research Sites (SCRS) has introduced a new data intelligence tool, the Eagle Insights Dashboard, designed to enhance the evaluation of clinical trial site performance.This innovative platform allows clinical trial sponsors and Contract Research Organizations (CROs) to assess their effectiveness through a comprehensive scoring system. The score aggregates various metrics, including study start-up efficiency, communication quality, and the diversity of patient populations.
A stethoscope on a medical chart in a dimly lit clinic room

Oct 20, 2026

London’s Emerald secures €1.66 million to scale its preventive healthcare platform

Emerald, a London-based preventive healthcare platform, has successfully raised €1.66 million, bringing its total funding to €3.44 million. This latest round includes a significant grant from Innovate UK and additional venture capital, highlighting a growing interest in preventive health solutions.The recent funding comprises an €832.2k grant from Innovate UK, marking the second award the company has received from this organization, alongside an equal amount in venture capital. New investors, in
A flat illustration of a surgical scalpel on a surgical drape

Oct 20, 2026

London-based “Surgical Intelligence” company XRlabs raises €7.48 million to bring AI into the operating room

XRlabs, a London-based company focused on integrating AI into surgical practices, has successfully secured €7.48 million ($8.4 million) in Seed funding to enhance its innovative offerings.Led by Playground Global, a venture firm specializing in DeepTech, the funding round also saw participation from Eka Ventures. Notably, Omar Ishrak, former Chairman and CEO of Medtronic, has joined XRlabs as Chair of its Board of Directors. The company, founded by neurosurgeon Dr. Ali Haddad in 2024, aims to re